We are live on ! Find out more
BANX

ArrowMark Financial

16 hedge funds and large institutions have $27.3M invested in ArrowMark Financial in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less capital invested

Capital invested by funds: $28.9M → $27.3M (-$1.58M)

11% less funds holding

Funds holding: 1816 (-2)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
8
Closed
3
Calls
Puts
Net Calls
Net Calls Change

BANX Hedge Fund Activity: Q3 2015 in Review

16 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in ArrowMark Financial (BANX) for Q3 2015, worth a combined $27.3M — down 5.5% from $28.9M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BANX and 1 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 4 added.

The largest buyer was Punch & Associates Investment Management, adding an estimated $823K. The largest seller was Confluence Investment Management, exiting entirely with an estimated $1.2M sold.

  • 16 institutional investors held ArrowMark Financial (BANX) as of Q3 2015, down from 18 in Q2 2015.
  • Funds reported $27.3M of ArrowMark Financial stock for Q3 2015, down 5.5% quarter-over-quarter.
  • 1 fund opened new ArrowMark Financial positions in Q3 2015 and 3 closed out, a net change of -2 holders.
  • The largest ArrowMark Financial buyer in Q3 2015 was Punch & Associates Investment Management, an estimated $823K added.
  • The largest ArrowMark Financial seller in Q3 2015 was Confluence Investment Management, an estimated $1.2M sold.

Based on aggregated 13F filings for Q3 2015.